Trial intelligence / Profile preview

Efficacy and Safety of Vardenafil in Erectile Dysfunction

NCT00654914Phase 3Completed

Sponsor
Bayer
Start
May 2003
Primary completion
Feb 2004
Modality
Small Molecules
01

Overview

A Phase 3 trial of vardenafil in erectile dysfunction (ED), sponsored by Bayer. Started May 2003; status: completed.

02

Drugs

vardenafil
03

Conditions

erectile dysfunction (ED)

Beyond the preview

Go deeper on NCT00654914.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00654914.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call